A novel soluble guanylate cyclase activator, avenciguat, in combination with empagliflozin, protects against renal and hepatic injury in diabetic db/db mice.

一种新型可溶性鸟苷酸环化酶激活剂 avenciguat 与 empagliflozin 联合使用，可保护糖尿病 db/db 小鼠免受肾脏和肝脏损伤